zolpidem

(redirected from Zolpimist)
Also found in: Dictionary.
Related to Zolpimist: Edluar

zolpidem

 [zōl-pi´dem]
a non-benzodiazepinesedative and hypnotic used orally as the tartrate salt in the short-term treatment of insomnia.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

zol·pi·dem

(zol'pi-dĕm),
A sedative/hypnotic drug useful for treating anxiety and resembling benzodiazepines in its pharmacology but differing somewhat in chemical structure. Unlike benzodiazepines, zolpidem lacks prominent anticonvulsant properties, and less tolerance may develop with its use.
Farlex Partner Medical Dictionary © Farlex 2012

zolpidem

(zōl′pə-dĕm′)
n.
A non-benzodiazepine sleep-inducing drug, C19H21N3O, used in its tartrate form to treat insomnia.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

zolpidem

An imidazopyridine HYPNOTIC drug used for the short-term treatment of INSOMNIA. A brand name is Stilnoct.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

zol·pi·dem

(zol'pi-dĕm)
A sedative/hypnotic drug useful for treating anxiety and resembling benzodiazepines in its pharmacology but differing somewhat in chemical structure. Unlike benzodiazepines, zolpidem lacks prominent anticonvulsant properties, and less tolerance may develop with its use.
Medical Dictionary for the Dental Professions © Farlex 2012
References in periodicals archive ?
(NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today the publication of a clinical study in the journal Pharmacy and Pharmacology, demonstrating that ZolpiMist, Aytu BioScience's lingual spray formulation of zolpidem, achieves sleep onset more quickly than the oral tablet form of zolpidem (brand name Ambien) in patients seeking short-term treatment for insomnia.
United States-based NovaDel Pharma has sold its remaining assets, which included ZolpiMist NDA, a license agreement and related global intellectual property to Amherst Pharmaceuticals.
Nausea and vomiting are treated with Alliance Pharma's Buccastem and GlaxoSmithKline's Zofran, while Columbia Labs features a testosterone replacement with Striant SR, and NovaDel appeals to insomnia patients with Zolpimist.
Zolpidem is a generic drug that is marketed under a number of different brand names, including Ambien, Zolpimist, Edluar, Hypogen, Somidem and Ivedal.
Additionally, with the recent expansion of Aytu's therapeutic portfolio, that now includes ZolpiMist and Tuzistra XR, this revised commercial arrangement enables us to employ a more distinct focus on primary care physicians to grow the entire product portfolio, while Acerus increases the promotional focus on Natesto with key specialists.'
These behaviors appear to be more common with Lunesta, Sonata, Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist than other prescription medicines used for sleep.
Pharmaceutical company NovaDel Pharma (NVDL.PK) on Friday confirmed the sale of the remaining assets of the ZolpiMist NDA, a license agreement and related global intellectual property to Amherst Pharmaceuticals.
This transaction, as contemplated, does not include the NitroMist or ZolpiMist intellectual property or licenses.
Evidence of this association was so compelling, the Food and Drug Administration recently announced that it is requiring manufacturers of Ambien, Ambien CR, Zolpimist, and Edluar, sleep aids that contain zolpidem, to lower recommended doses.
Cur rent brands include DexPak, Bupap, Lodrane, Tussi-Caps, Orbivan, Zolpimist and Zolvit.
Earlier today, Aytu BioScience announced the accelerated launch of ZolpiMist, an oral spray formulation of zolpidem tartrate and the only FDA-approved oral spray prescription sleep aid.